This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Delbert G.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kane: In talking ...

John M. Kane, MD: When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. Someone who ...

John M. Kane, MD: So a lot of interesting points. I think one of the studies that was probably most informative on that was Tyrone Cannon’s study of patients who were converting from the prodrome to ...

Relapses are often associated with a major disruption in a person’s life, such as a job loss or legal problem. They’re usually preceded by early warning signs that appear a week or so in advance, says ...

The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...

Schizophrenia and bipolar I disorder are two conditions that have many differences between them. A class of medicines called antipsychotics can be used to treat both conditions but may cause unwanted ...

Downsides with current options leave a large unmet need for new therapies, researcher says ...